CPT code 87529: HSV DNA test, amplified probe2026 Medicare lab fee · Clinical Laboratory Fee Schedule

Amplified-probe HSV DNA testing detects herpes simplex virus in a specimen when clinicians evaluate suspected active infection, including mucocutaneous or central nervous system disease.

CMS CLFS 2026 Q4Effective Oct 1, 2026Same amount nationwide222.1K Medicare services in 2024

Medicare pays $35.09 for 87529 under the 2026 Clinical Laboratory Fee Schedule: one national amount, the same in every state and setting.

Medicare lab fee · CLFS 2026 Q4

National CLFS amount

$35.09

In effect since Jan 1, 2026. The same amount in every state, payment locality and setting.

Geographic adjustment
None
Office vs facility
Same
Since 2020
Unchanged
CMS updates
Quarterly

Medicare pays the lesser of the lab’s charge and this amount. Patients usually owe no Part B deductible or coinsurance for covered clinical lab tests.

On this page 8 sections
  1. Medicare lab fee
  2. What 87529 covers
  3. How it’s paid
  4. Amount history
  5. Similar tests
  6. Related codes
  7. Billing questions
  8. Sources

What 87529 covers

This molecular test detects herpes simplex virus DNA using an amplified-probe method. Clinicians may order it to evaluate suspected active HSV infection, including mucocutaneous disease or possible central nervous system infection. Lesion swabs and cerebrospinal fluid are common specimen contexts. Testing is performed and reported by a clinical laboratory.

Report this code for the HSV amplified-probe detection assay, not for a viral-load measurement. The code represents the test rather than a number of viral copies. Medicare pays it under the CLFS at one national amount; the 2026 national CLFS amount is $35.09, unchanged since 2020. Payment is the same across localities, with no office or facility difference. The test is paid only from the CLFS, not the physician fee schedule.

This summary was written with AI assistance from CMS Clinical Laboratory Fee Schedule data. Amounts on this page come directly from CMS files.

How Medicare pays 87529

Clinical lab tests aren’t priced like physician services. They’re paid from their own fee schedule, with its own rules. See the whole lab fee schedule.

One national amount

CMS sets a single Clinical Laboratory Fee Schedule amount for 87529. There’s no geographic (GPCI) adjustment, so it pays the same in every state and payment locality.

No office or facility rate

Lab tests aren’t built from relative value units, so there’s no office and facility split: the place of service doesn’t change the CLFS amount.

Updated every quarter

CMS republishes the CLFS each quarter. New tests, often proprietary laboratory analyses (PLA codes), join during the year; existing amounts are updated each January.

Excluded from the physician fee schedule

The physician fee schedule lists 87529 with status X (excluded by statute), so the test itself is paid only from the CLFS.

87529 on the lab fee schedule since 2020

87529 · CLFS 2026 Q4 (current)

$35.09

Unchanged since Jan 1, 2020

Amount in each year’s latest CLFS release · bars start at $0

27 quarterly CLFS releases on file, first CLFS 2020 Q1. A code missing from a quarter wasn’t on that release.

87529 compared with similar tests

87528HSV DNA testDirect probe$20.05
Both detect HSV DNA, but 87528 is for a direct-probe method; this code is for an amplified-probe method.
87530HSV DNAQuantitative viral level$42.84
87530 measures HSV DNA quantitatively. This code reports amplified-probe detection rather than viral quantity.
87255HSV isolationCulture with identification$33.86
87255 represents viral culture. This code is for amplified-probe HSV DNA detection.

87529 billing questions

When is this code appropriate?

Use it for an amplified-probe test that detects HSV DNA in a submitted specimen, such as during evaluation of a suspected active HSV infection. It is a detection test, not a quantitative viral-load assay.

How does it differ from 87528?

Both test for HSV DNA, but 87528 describes a direct-probe method. This code is for the amplified-probe method.

How does it differ from 87530?

87530 is the quantitative HSV DNA test. Use this code for amplified-probe detection rather than measurement of viral quantity.

Does Medicare pay this through the physician fee schedule?

No. Medicare pays the test through the CLFS at one national amount, without locality or office-versus-facility payment differences.

Where this amount comes from

FeeBase reads lab amounts directly from the CMS Clinical Laboratory Fee Schedule file for the quarter: one row per code, with its payment indicator and national amount. Contractor-priced tests are labeled, never given a made-up amount. Amounts are Medicare payment limits, not a patient’s bill or a commercial rate.

CMS CLFS 2026 Q4 · effective Oct 1, 2026 through the day before Jan 1, 2027

Show the CMS file line behind this amount
CLFS row for 87529PUF_CLFS_CY2026_Q4V1.csv, line 2,031 (CLFS 2026 Q4)

Open CMS sourceHow we source rates

Did this answer your question about what Medicare pays for 87529?

Tell us what you were actually trying to work out. We’ll answer you directly, or build the page that does.

Fee sheets

Put 87529 and the rest of your codes on one sheet

Your codes at your locality, with payer contracts beside Medicare.

Build my fee sheet